SFX by Ex Libris Inc.

Title:	Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Source:	Nature [0028-0836] Pugh, T J yr:2012

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Jones, David T W T. "Dissecting the genomic complexity underlying medulloblastoma." Nature 487.7409 (2012): 100-105.
description	2.	Gilbertson, R. "Novel mutations target distinct subgroups of medulloblastoma." Nature 488.7409 (2012): 43-48.
description	3.	Eberhart, Charles G. "Molecular diagnostics in embryonal brain tumors." Brain pathology 21.1 (2011): 96-104.
description	4.	Jepsen, K. "Combinatorial roles of the nuclear receptor corepressor in transcription and development." Cell 102.6 (2000): 753-763.
description	5.	BENIGNI, R. "Exploring In Vitro/In Vivo Correlation: Lessons Learned from Analyzing Phase I Results of the US EPA's ToxCast Project." Environmental carcinogenesis & ecotoxicology reviews 28.4 (2010): 272-286.
description	6.	Hawkins, William D. "Subgroup-specific structural variation across 1,000 medulloblastoma genomes." Nature 488.7409 (2012): 49-56.
description	7.	Northcott, Paul A. "Medulloblastomics: the end of the beginning." Nature Reviews. Cancer 12.12 (2012): 818-834.
description	8.	Downing, James R. "The pediatric cancer genome project." Nature Genetics 44.6 (2012): 619-622.
description	9.	Taylor, Michael D. "Molecular subgroups of medulloblastoma: the current consensus." Acta neuropathologica 123.4 (2011): 465-72.
description	10.	Northcott, Paul A. "Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples." Acta neuropathologica 123.4 (2011): 615-626.
description	11.	Pfaff, E. "TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma." Journal of clinical oncology 28.35 (2010): 5188-96.
description	12.	Massimino, M. "Childhood medulloblastoma." Critical reviews in oncology/hematology 79.1 (2010): 65-83.
description	13.	Marino, S. "Cerebellar granule cells: Insights into proliferation, differentiation, and role in medulloblastoma pathogenesis." The international journal of biochemistry & cell biology 41.3 (2009): 435-445.
description	14.	Thompson, Margaret C C. "Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations." Journal of clinical oncology 24.12 (2006): 1924-31.
description	15.	Ng, H. "The molecular genetics of central nervous system tumors." Pathology 30.2 (1998): 196-202.
description	16.	ZHAO, W. "Reproducibility and Validity of a Chinese Food Frequency Questionnaire." Biomedical and environmental sciences 23.Supplement (2010): 1-38.
description	17.	Benigni, R. "Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for Predictive Toxicology." Chemical reviews 111.4 (2011): 2507-2536.
description	18.	Pfister, Stefan M. "Molecular diagnostics of CNS embryonal tumors." Acta neuropathologica 120.5 (2010): 553-566.
description	19.	Reif, D. "Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast Data." Environmental health perspectives 118.12 (2010): 1714-1720.
description	20.	Gadd, S. "Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets." Laboratory Investigation 90.5 (2010): 724-738.